
mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting Data from 2 major phase 3 trials have demonstrated that progression to clinically definite multiple sclerosis (MS) can be prevented or delayed with early rather than delayed therapy. Two regimens of subcutaneous interferon beta-1a (IFNb) were evaluated in patients who…
Read more »
Diabetic neuropathy may be linked to metabolic risk factors
Neuropathy is a common, disabling complication of diabetes, and its incidence in India is growing as the prevalence of diabetes—especially type 2 diabetes—continues to rise nationally. India has the world’s largest diabetic population, with an estimated 62 million people diagnosed with the condition, according to the Indian Council of Medical…
Read more »